{"id":852073,"date":"2025-05-17T08:03:12","date_gmt":"2025-05-17T12:03:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\/"},"modified":"2025-05-17T08:03:12","modified_gmt":"2025-05-17T12:03:12","slug":"iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\/","title":{"rendered":"Iovance Shareholders Should Contact Shareholder Rights Firm Regarding Potential Legal Claims"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">NEW YORK<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">May 17, 2025<\/span><\/span> \/PRNewswire\/ &#8212;\u00a0Julie &amp; Holleman LLP, a top-tier shareholder rights firm, is investigating potential claims against Iovance\u00a0 Biotherapeutics, Inc. (Nasdaq: IOVA) and its executives for recent losses suffered by the company&#8217;s stockholders.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1823134\/Julie_Holleman_LLP1_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1823134\/Julie_Holleman_LLP1_Logo.jpg\" title=\"Julie &amp; Holleman LLP is a boutique law firm that focuses on shareholder litigation, including derivative actions, mergers and acquisitions cases, securities fraud class actions, and corporate investigations. (PRNewsfoto\/Julie &amp; Holleman LLP)\" alt=\"Julie &amp; Holleman LLP is a boutique law firm that focuses on shareholder litigation, including derivative actions, mergers and acquisitions cases, securities fraud class actions, and corporate investigations. (PRNewsfoto\/Julie &amp; Holleman LLP)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>For a free consultation, please visit <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4430203-1&amp;h=3066346504&amp;u=https%3A%2F%2Fjulieholleman.com%2Fiovance-biotherapeutics-inc%2F&amp;a=https%3A%2F%2Fjulieholleman.com%2Fiovance-biotherapeutics-inc%2F\" target=\"_blank\" rel=\"nofollow\">https:\/\/julieholleman.com\/iovance-biotherapeutics-inc\/<\/a>. You may also contact partner <span class=\"xn-person\">Scott Holleman<\/span> at (929) 415-1020 or by email at <a href=\"mailto:scott@julieholleman.com\" target=\"_blank\" rel=\"nofollow\">scott@julieholleman.com<\/a>.<\/p>\n<p>According to a complaint recently filed in federal court, Iovance and its executives misled investors by exaggerating the company&#8217;s financial prospects and downplaying risk factors affecting the company&#8217;s growth potential. Among other things, the complaint <span>alleges<\/span> that the company concealed that it was not equipped to generate and drive demand or was otherwise ill equipped to capitalize upon the purported existing demand for its treatments through its network of approved treatment centers.<\/p>\n<p>Julie &amp; Holleman, whose attorneys have helped secure hundreds of millions of dollars in prior cases, is investigating legal claims against Iovance, its executives, and potentially also the company&#8217;s board of directors.<\/p>\n<p>FIRM INFORMATION<\/p>\n<p>Julie &amp; Holleman is a boutique law firm that focuses on shareholder litigation, including derivative actions, mergers and acquisitions cases, securities <span>fraud<\/span> class actions, and corporate investigations. The firm&#8217;s attorneys litigate in state and federal courts across the nation and have helped secure hundreds of millions of dollars for aggrieved companies and their shareholders. For more information about the firm, please visit <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4430203-1&amp;h=334271042&amp;u=https%3A%2F%2Fwww.julieholleman.com%2F&amp;a=www.julieholleman.com\" target=\"_blank\" rel=\"nofollow\">www.julieholleman.com<\/a>. This notice may constitute attorney advertising.<\/p>\n<p>Julie &amp; Holleman LLP<br \/>W. <span class=\"xn-person\">Scott Holleman, Esq.<\/span><br \/>157 East 86th Street<br \/>4th Floor<br \/><span class=\"xn-location\">New York, NY<\/span> 10028<br \/>(929) 415-1020<br \/><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4430203-1&amp;h=334271042&amp;u=https%3A%2F%2Fwww.julieholleman.com%2F&amp;a=www.julieholleman.com\" target=\"_blank\" rel=\"nofollow\">www.julieholleman.com<\/a><\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY90479&amp;sd=2025-05-17\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims-302458275.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims-302458275.html<\/a><\/p>\n<p>SOURCE  Julie &amp; Holleman LLP<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY90479&amp;Transmission_Id=202505170800PR_NEWS_USPR_____NY90479&amp;DateId=20250517\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK , May 17, 2025 \/PRNewswire\/ &#8212;\u00a0Julie &amp; Holleman LLP, a top-tier shareholder rights firm, is investigating potential claims against Iovance\u00a0 Biotherapeutics, Inc. (Nasdaq: IOVA) and its executives for recent losses suffered by the company&#8217;s stockholders. For a free consultation, please visit https:\/\/julieholleman.com\/iovance-biotherapeutics-inc\/. You may also contact partner Scott Holleman at (929) 415-1020 or by email at scott@julieholleman.com. According to a complaint recently filed in federal court, Iovance and its executives misled investors by exaggerating the company&#8217;s financial prospects and downplaying risk factors affecting the company&#8217;s growth potential. Among other things, the complaint alleges that the company concealed that it was not equipped to generate and drive demand or was otherwise ill equipped to capitalize upon the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Iovance Shareholders Should Contact Shareholder Rights Firm Regarding Potential Legal Claims&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-852073","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Iovance Shareholders Should Contact Shareholder Rights Firm Regarding Potential Legal Claims - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Iovance Shareholders Should Contact Shareholder Rights Firm Regarding Potential Legal Claims - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK , May 17, 2025 \/PRNewswire\/ &#8212;\u00a0Julie &amp; Holleman LLP, a top-tier shareholder rights firm, is investigating potential claims against Iovance\u00a0 Biotherapeutics, Inc. (Nasdaq: IOVA) and its executives for recent losses suffered by the company&#8217;s stockholders. For a free consultation, please visit https:\/\/julieholleman.com\/iovance-biotherapeutics-inc\/. You may also contact partner Scott Holleman at (929) 415-1020 or by email at scott@julieholleman.com. According to a complaint recently filed in federal court, Iovance and its executives misled investors by exaggerating the company&#8217;s financial prospects and downplaying risk factors affecting the company&#8217;s growth potential. Among other things, the complaint alleges that the company concealed that it was not equipped to generate and drive demand or was otherwise ill equipped to capitalize upon the &hellip; Continue reading &quot;Iovance Shareholders Should Contact Shareholder Rights Firm Regarding Potential Legal Claims&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-17T12:03:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1823134\/Julie_Holleman_LLP1_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Iovance Shareholders Should Contact Shareholder Rights Firm Regarding Potential Legal Claims\",\"datePublished\":\"2025-05-17T12:03:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\\\/\"},\"wordCount\":288,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1823134\\\/Julie_Holleman_LLP1_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\\\/\",\"name\":\"Iovance Shareholders Should Contact Shareholder Rights Firm Regarding Potential Legal Claims - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1823134\\\/Julie_Holleman_LLP1_Logo.jpg\",\"datePublished\":\"2025-05-17T12:03:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1823134\\\/Julie_Holleman_LLP1_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1823134\\\/Julie_Holleman_LLP1_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Iovance Shareholders Should Contact Shareholder Rights Firm Regarding Potential Legal Claims\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Iovance Shareholders Should Contact Shareholder Rights Firm Regarding Potential Legal Claims - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\/","og_locale":"en_US","og_type":"article","og_title":"Iovance Shareholders Should Contact Shareholder Rights Firm Regarding Potential Legal Claims - Market Newsdesk","og_description":"PR Newswire NEW YORK , May 17, 2025 \/PRNewswire\/ &#8212;\u00a0Julie &amp; Holleman LLP, a top-tier shareholder rights firm, is investigating potential claims against Iovance\u00a0 Biotherapeutics, Inc. (Nasdaq: IOVA) and its executives for recent losses suffered by the company&#8217;s stockholders. For a free consultation, please visit https:\/\/julieholleman.com\/iovance-biotherapeutics-inc\/. You may also contact partner Scott Holleman at (929) 415-1020 or by email at scott@julieholleman.com. According to a complaint recently filed in federal court, Iovance and its executives misled investors by exaggerating the company&#8217;s financial prospects and downplaying risk factors affecting the company&#8217;s growth potential. Among other things, the complaint alleges that the company concealed that it was not equipped to generate and drive demand or was otherwise ill equipped to capitalize upon the &hellip; Continue reading \"Iovance Shareholders Should Contact Shareholder Rights Firm Regarding Potential Legal Claims\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\/","og_site_name":"Market Newsdesk","article_published_time":"2025-05-17T12:03:12+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1823134\/Julie_Holleman_LLP1_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Iovance Shareholders Should Contact Shareholder Rights Firm Regarding Potential Legal Claims","datePublished":"2025-05-17T12:03:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\/"},"wordCount":288,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1823134\/Julie_Holleman_LLP1_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\/","name":"Iovance Shareholders Should Contact Shareholder Rights Firm Regarding Potential Legal Claims - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1823134\/Julie_Holleman_LLP1_Logo.jpg","datePublished":"2025-05-17T12:03:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1823134\/Julie_Holleman_LLP1_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1823134\/Julie_Holleman_LLP1_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/iovance-shareholders-should-contact-shareholder-rights-firm-regarding-potential-legal-claims\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Iovance Shareholders Should Contact Shareholder Rights Firm Regarding Potential Legal Claims"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/852073","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=852073"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/852073\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=852073"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=852073"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=852073"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}